The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells

Targeting vascular (endothelial) dysfunction

(2016) Andreas Daiber et al.   BRITISH JOURNAL OF PHARMACOLOGY

From C-Reactive Protein to Interleukin-6 to Interleukin-1

(2016) Paul M Ridker   CIRCULATION RESEARCH

Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium

(2016) Lifei Tao et al.   Journal of Neuroinflammation

Vascular smooth muscle cell in atherosclerosis

(2015) D. A. Chistiakov et al.   Acta Physiologica

Comparison of angiotensin-(1–7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice

(2015) Jianmin Yang et al.   ATHEROSCLEROSIS

Angiotensin-(1–7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways

(2015) Xiang Xiao et al.   EXPERIMENTAL CELL RESEARCH

The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos

(2015) Lin Wang et al.   PLoS One

Angiotensins as therapeutic targets beyond heart disease

(2015) Danielle Gomes Passos-Silva et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Angiotensin-(1–7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway

(2015) Ji C. Bihl et al.   VASCULAR PHARMACOLOGY

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats

(2014) Susana Vallejo et al.   Cardiovascular Diabetology

Angiotensin-(1–7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2

(2014) Ebaa M. Alzayadneh et al.   CELLULAR SIGNALLING

A century old renin–angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology

(2014) Pitchai Balakumar et al.   CELLULAR SIGNALLING

The Ang-(1–7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle

(2014) María Gabriela Morales et al.   CLINICAL SCIENCE

Inducible Nitric Oxide Synthase as a Possible Target in Hypertension

(2014) Gustavo Oliveira-Paula et al.   CURRENT DRUG TARGETS

Angiotensin II and Vascular Injury

(2014) Augusto C. Montezano et al.   CURRENT HYPERTENSION REPORTS

Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

(2014) Fan Jiang et al.   Nature Reviews Cardiology

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

(2013) Brendan M. Everett et al.   AMERICAN HEART JOURNAL

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

(2013) AC Simões e Silva et al.   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin-(1–7) Protects From Experimental Acute Lung Injury

(2013) Nadine Klein et al.   CRITICAL CARE MEDICINE

Angiotensin-(1–7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling

(2013) Elizabeth D. Moore et al.   FREE RADICAL BIOLOGY AND MEDICINE

Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas

(2013) Concepción Peiró et al.   JOURNAL OF PHYSIOLOGY-LONDON

Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature

(2012) Aurelie Nguyen Dinh Cat et al.   ANTIOXIDANTS & REDOX SIGNALING

Increased iNOS activity in vascular smooth muscle cells from diabetic rats: Potential role of Ca2+/calmodulin-dependent protein kinase II delta 2 (CaMKIIδ2)

(2012) Natalia Di Pietro et al.   ATHEROSCLEROSIS

The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles

(2012) P. Lacolley et al.   CARDIOVASCULAR RESEARCH

Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension

(2012) Rodrigo Araujo Fraga-Silva et al.   CURRENT HYPERTENSION REPORTS

Angiotensin II-Induced Mitochondrial Nox4 Is a Major Endogenous Source of Oxidative Stress in Kidney Tubular Cells

(2012) Su-Mi Kim et al.   PLoS One

Angiotensin-(1–7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1

(2011) LaTronya T. McCollum et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Could Direct Inhibition of Inflammation Be the “Next Big Thing” in Treating Atherosclerosis?

(2010) Pradeep Natarajan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammation

(2010) A. R. Brasier   CARDIOVASCULAR RESEARCH

Nitric oxide synthases in the pathogenesis of cardiovascular disease

(2010) Hiroaki Shimokawa et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration

(2010) Feng Zhang et al.   PLoS One

Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity

(2009) T. Romacho et al.   DIABETOLOGIA

The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning

(2009) Nuria Lafuente et al.   JOURNAL OF HYPERTENSION